1. Home
  2. OHI vs RDY Comparison

OHI vs RDY Comparison

Compare OHI & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Omega Healthcare Investors Inc.

OHI

Omega Healthcare Investors Inc.

HOLD

Current Price

$44.01

Market Cap

13.1B

Sector

Real Estate

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$14.22

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OHI
RDY
Founded
N/A
1984
Country
United States
India
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.1B
11.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OHI
RDY
Price
$44.01
$14.22
Analyst Decision
Buy
Strong Buy
Analyst Count
10
1
Target Price
$45.67
$16.90
AVG Volume (30 Days)
2.0M
1.2M
Earning Date
02-04-2026
01-22-2026
Dividend Yield
6.09%
0.50%
EPS Growth
31.87
9.95
EPS
1.80
0.79
Revenue
$1,150,200,000.00
$3,851,623,984.00
Revenue This Year
$12.80
$6.16
Revenue Next Year
$8.35
$2.57
P/E Ratio
$24.44
$18.02
Revenue Growth
13.72
14.10
52 Week Low
$35.04
$12.26
52 Week High
$46.36
$16.17

Technical Indicators

Market Signals
Indicator
OHI
RDY
Relative Strength Index (RSI) 46.22 57.48
Support Level $44.03 $13.90
Resistance Level $44.95 $14.16
Average True Range (ATR) 0.75 0.16
MACD -0.26 0.01
Stochastic Oscillator 19.66 95.04

Price Performance

Historical Comparison
OHI
RDY

About OHI Omega Healthcare Investors Inc.

Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. Omega has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: